|Description||Anle138b is a novel fluorescent oligomer modulator and an aggregation inhibitor. In vitro, anle138b blocked the formation of pathological aggregates of prion protein (PrPSc) and of α-synuclein.|
|Synonyms||5-(1,3-benzodioxol-5-yl)-3-(3-bromophenyl)-1H-pyrazole; 3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole; anle138b|
|Storage||Store in a cool and dry place (or refer to the Certificate of Analysis).|
|Boiling Point||527.3±50.0 ℃ at 760 Torr|
Neurodazine, a cell-permeable trisubstituted imidazole compound, induces neurogenesis of non-pluripotent C2C12 myoblasts and cells derived from mature human ske...
Cyclandelate is an effective inhibitor of rat hepatic acycloenzyme A: cholesterol acyltransferase (ACAT) with IC50 of 80 μM.
BAMB-4 is a new membrane-permeable inhibitor against inositol-1,4,5-trisphosphate-3-kinase A((ITPKA). It exhibits the lowest inhibition frequency among the InsP...
Octodrine is a local anesthetic and vasoconstrictor, shows leucine aminotransferase inhibition.
Carnosic acid has medicinal properties, is a potent antioxidant and protects skin cells against UV-A radiation (photoprotection). Studies in animals have also f...
Source from the seeds of Schisandra chinensis (Turcz.) Baill, shows good effect in lowering the serum glutamic-pyruvic transaminase level of the patients suffer...
Dioscin is a saponin extracted and isolated from Polygonatum Zanlanscianense Pamp, showing antitumor activities.
ON-013100, a cell cycle inhibitor, altered the growth and cell cycle status of MCL lines and potently inhibited the expression of several important molecules, i...
Difluprednate (difluoroprednisolone butyrate acetate, or DFBA) is a synthetic difluorinated prednisolone derivative, it is originally developed for dermatologic...
Cysteamine has been shown to increase intracellular glutathione levels in cystinotic cells, thus restoring the altered redox state of the cells.
KAT681 is a novel liver-selective thyromimetic displaying strong hypolipidemic properties without cardio-toxic effects.
CDK2, a member of the eukaryotic S/T protein kinase family, catalyzes the phosphoryl transfer of ATP γ-phosphate to serine or threonine hydroxyl (denoted as S0/...
TPI-1 selectively increased SHP-1 phospho-substrates (pLck-pY394, pZap70, and pSlp76) in Jurkat T cells but had little effects on pERK1/2 or pLck-pY505 regulate...
Amifampridine is a drug, predominantly in the treatment of a number of rare muscle diseases. It is used to treat many of the congenital myasthenic syndromes, pa...
Qc 1 is a reversible, non-competitive inhibitor of threonine dehydrogenase (TDH) (IC50 ~500 nM), with no detectable inhibition of other dehydroxygenase enzymes ...
BIBF 1202 is the major in-vivo metabolite of BIBF 1120, which is an oral triple angiokinase inhibitor targeting VEGFR, PDGFR, FGFR. It is a related compound of ...
(±)-CPSI 1306 has been found to be a MIF inhibitor and could also be used in the synthesis of some isoxazolines compounds.
CCMQ is an inhibitor of homoquinolinic acid binding to non-NMDA sensitive sites. It is combined with [3H]-homoquinolinic acid to characterize NR2B-containing NM...
Revefenacin, also knownc as TD-4208 and GSK1160724, is potent and selective muscarinic receptor antagonist in development for the treatment of COPD.